Phase 4 Duodenal Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP
SedationERCPDuodenal Spasm
Ankara City Hospital Bilkent120 enrolled1 locationNCT07333859
Recruiting
Phase 4
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Neuro Endocrine TumoursPDAC - Pancreatic Ductal AdenocarcinomaPancreas Adenocarcinoma+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)400 enrolled1 locationNCT07262957
Not Yet Recruiting
Phase 4
Effects of dipeptidyl peptidase IV (DPP-IV) inhibition (vildagliptin) on plasma concentrations of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) during intraduodenal fat infusion.
Physiological study to investigate the effects of intraduodenal fat in healthy volunteers.
Outcomes may have implications for type 2 diabetes and obesity.
Royal Adelaide Hospital16 enrolled1 locationACTRN12610001104044
Not Yet Recruiting
Phase 4
A randomised, controlled trial of Helicobacter pylori (H.pylori) eradication therapy plus oral iron therapy versus oral iron therapy alone in patients with iron deficiency of obscure origin
Iron deficiency with no cause found on gastroscopy, colonoscopy and duodenal biopsy
St Vincent's Health (Melbourne) Ltd105 enrolledACTRN12607000287437